Imara Inc. announced the appointment of Edward R. Conner, M.D., to its Board of Directors. Dr. Conner has more than 15 years of global leadership experience overseeing clinical development across multiple therapeutic areas and rare diseases. Dr. Conner will replace James McArthur, Ph.D., who is stepping down from the Board of Directors. Dr. Conner currently serves as Senior Vice President and Chief Medical Officer at Audentes Therapeutics, where he is responsible for leading the global clinical development strategy and oversees clinical development, clinical operations, regulatory affairs, medical affairs and patient advocacy. Imara also announced that its Chief Medical Officer, Willem Scheele, M.D., is leaving the company to begin the next chapter in his career.